RBRKHIGH SIGNALFINANCIAL10-K

RBRK demonstrates substantial revenue growth and meaningful improvement in profitability metrics, though the company remains unprofitable with significantly expanded operations.

The company's revenue grew substantially to $1.3B while losses narrowed considerably, suggesting improving unit economics and operational leverage. The notable expansion in total assets and accounts receivable indicates rapid business scaling, though investors should monitor whether this growth trajectory is sustainable given the company's limited operating history with newer product offerings.

Comparing 2026-03-19 vs 2025-03-20View on EDGAR →
FINANCIAL ANALYSIS

RBRK's financial profile shows a rapidly expanding business with revenue approaching $1.3B and substantially reduced losses, indicating improving operational efficiency. The balance sheet roughly doubled in size with total assets reaching $2.8B, while accounts receivable grew meaningfully to $256.8M, consistent with the revenue expansion. Capital expenditures increased notably to $29.6M, reflecting infrastructure investments to support the company's growth trajectory, though the business remains loss-making despite clear progress toward profitability.

FINANCIAL STATEMENT CHANGES
Total Assets
Balance Sheet
+94.4%
$1.4B$2.8B

Asset base grew 94.4% — expansion through organic growth, acquisitions, or capital deployment.

Capital Expenditure
Cash Flow
+75.5%
$16.9M$29.6M

Capital expenditure jumped 75.5% — major investment cycle underway; assess returns on deployment.

Gross Profit
P&L
+69.8%
$620.8M$1.1B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Net Income
P&L
+69.8%
-$1.2B-$348.8M

Net income grew 69.8% — bottom-line growth signals improving overall business health.

Operating Income
P&L
+69.5%
-$1.1B-$345.4M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Total Liabilities
Balance Sheet
+66.2%
$2.0B$3.3B

Liabilities grew 66.2% — significant increase in debt or obligations, assess impact on financial flexibility.

Revenue
P&L
+48.5%
$886.5M$1.3B

Strong top-line growth of 48.5% — accelerating demand or successful expansion into new markets.

Accounts Receivable
Balance Sheet
+44.6%
$177.6M$256.8M

Receivables surged 44.6% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Current Liabilities
Balance Sheet
+38.3%
$950.2M$1.3B

Current liabilities surged 38.3% — significant near-term obligations; verify ability to meet short-term debt.

Inventory
Balance Sheet
+35.7%
$4.2M$5.7M

Inventory surged 35.7% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

LANGUAGE CHANGES
NEW — 2026-03-19
PRIOR — 2025-03-20
ADDED
had 157,404,648 shares of Class A common stock outstanding, and 44,871,492 shares of Class B common stock outstanding.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 61 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 63 Item 7A.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 116 Item 9A.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 118 Item 13.
+7 more — sign up free →
REMOVED
had 103,167,994 shares of Class A common stock outstanding, and 86,610,633 shares of Class B common stock outstanding.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 59 I tem 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 61 I tem 7A.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 111 I tem 9A.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 113 I tem 13.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →